Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study - Scorecard - MDSpire

Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study

  • By

  • Lu Lu

  • Jian Hu

  • Peiyu Wang

  • Longting Du

  • Jing Xiao

  • Guoxiang Lu

  • Kui Zhou

  • Peng Chao

  • PoWuJu Wu

  • Zhiyong Zong

  • Liyu Chen

  • Lei Chen

  • Lin Chen

  • Dong Zhou

  • Weixi Xiong

  • May 1, 2026

  • 0 min

Share

Clinical Scorecard: Neurological Disorders in HIV Patients During the HAART Era: Findings from a Multicenter Cross-Sectional Study

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationIndividuals aged 16 and older diagnosed with HIV exhibiting neurological symptoms, including headache, dizziness, and cognitive impairment.
Care Setting

Key Highlights

  • Include neurobehavioral symptoms (8%) and cerebrovascular disorders (16%) for a complete overview.

Guideline-Based Recommendations

Diagnosis

    Management

    • Implement HAART as early as possible to manage HIV and associated neurological symptoms, including cognitive impairment.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Early identification and treatment of HIV, including HAART, can mitigate the risk of neurological disorders.

        Clinical Best Practices

        • Encourage routine HIV screening in patients presenting with neurological symptoms to facilitate early diagnosis and treatment.

        References

        Original Source(s)

        Neurological manifestations in people with HIV in HAART era: a cross-sectional multicenter study

        • by Lu Lu, Jian Hu, Peiyu Wang, Longting Du, Jing Xiao, Guoxiang Lu, Kui Zhou, Peng Chao, PoWuJu Wu, Zhiyong Zong, Liyu Chen, Lei Chen, Lin Chen, Dong Zhou, Weixi Xiong

        • May 1, 2026

        Related Content

        Lipidomics Point to Obesity–Alzheimer's Link

        Study uses multi-omics tools to examine obesity-related pathways linked to neurodegeneration

        • May 26, 2026

        • 2 min
        Biomarker evidence of neurodegeneration in mid-life former rugby players

        High-Level Alzheimer Disease Neuropathological Change Following Iatrogenic Exposure